Modern neuroscience has revealed how mild cognitive impairment affects the brain's structure, chemistry, and function — knowledge that's transforming treatment approaches.
The Brain Regions Involved in Mild Cognitive Impairment
Key brain areas implicated in mild cognitive impairment include:
- Amygdala: The brain's threat-detection center becomes hyperactive in mild cognitive impairment, triggering excessive fear and stress responses
- Prefrontal Cortex: Responsible for rational thinking and emotional regulation — its function is often impaired by mild cognitive impairment
- Hippocampus: Memory and context processing; chronic mild cognitive impairment can affect its volume and function
- HPA Axis: The stress hormone system that, when dysregulated, drives many physical symptoms of mild cognitive impairment
Neurochemistry of Mild Cognitive Impairment
Mild Cognitive Impairment involves imbalances or dysregulation of key neurotransmitters including serotonin, dopamine, norepinephrine, and GABA — all targets of current treatments.
How Treatment Changes the Brain
Both therapy and medication produce measurable changes in brain function in mild cognitive impairment. CBT, for example, has been shown to normalize amygdala reactivity.
Neuroplasticity and Mild Cognitive Impairment
The brain retains its ability to change throughout life. This neuroplasticity means that with appropriate treatment and practice, the neural patterns underlying mild cognitive impairment can genuinely change.